Review
Sep 2026
Genome Profiling of Actionable Cancer Targets (NYU LG-PACT) for Clinical Patient Molecular Diagnostics and Treatment
The technical challenges of validating an NGS oncological diagnostic targeted assay for clinical grade accuracy and sensitivity for patient care are presented and how copy number alterations provide a more comprehensive description of the tumors genomic profile are shown.
Y. Yang, V. Vasudevaraja, J. Serrano et al.
· medRxiv · 0 citations